Therap: A Randomized Phase Ii Trial Of [Lu-177]-Psma-617 Theranostic Versus Cabazitaxel In Progressive Metastatic Castration-Resistant Prostate Cancer

Michael Hofman,Louise Emmett,John A Violet,Nicola Jane Lawrence,Scott Williams,Martin R. Stockler,Roslyn J Francis,Amir Iravani,Alison Yan Zhang,Andrew James Martin,Arun Azad,Sonia Yip,Ailsa Langford,Margaret Mary McJannett,Ian D. Davis, New Zealand Urogenital

JOURNAL OF CLINICAL ONCOLOGY（2019）

引用 5|浏览31

暂无评分

摘要

TPS332Background: Lutetium-177 [177Lu]-PSMA-617 is a novel radiolabelled small molecule that binds with high affinity to prostate-specific membrane antigen (PSMA), which is commonly overexpressed i...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要